Ming Yan, Chief Technology Officer at Cytek Biosciences, Inc. (CTKB), sold 40,000 shares at $9.71 ($388K) on 2023-04-19, disclosed to the SEC on 2023-04-20.
Scheduled sale ($388k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.71 | 20,000 | $194K | 50.0% |
| 2 | $9.71 | 20,000 | $194K | 50.0% |
| Total | $9.71 avg | 40,000 | $388K | 100% |
| Filing → |
| CTKB | SELL | 2024-03-19 | $270K | — | Filing → |
| CTKB | SELL | 2023-12-21 | $189K | — | Filing → |
| CTKB | SELL | 2023-11-21 | $121K | — | Filing → |